Study comparing short acting and long acting forms of drug used for increasing the uterine strength after surgical delivery of baby from mother.
Not Applicable
- Conditions
- Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2022/10/046407
- Lead Sponsor
- Dr Gita Nath
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients presenting for elective or emergency cesarean section under spinal anesthesia
Exclusion Criteria
Allergy to carbetocin or oxytocin
Any hemodynamic instability in the preoperative period
Seizures
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eed for second line uterotonic <br/ ><br>Timepoint: T1-after first line uterotonic <br/ ><br>
- Secondary Outcome Measures
Name Time Method To compare the hemodynamic effects of carbetocin and oxytocin in parturients coming for elective and emergency caesarean surgeries <br/ ><br>Timepoint: T1-5min after spinal <br/ ><br>T2-10min after spinal <br/ ><br>T3-15min after spinal <br/ ><br>T4-20min after spinal <br/ ><br>T5-25min after spinal <br/ ><br>T6-30min after spinal <br/ ><br>T7,8,9,10,11,12....EVERY 5min till end of surgery;Assessment of uterine tone by the surgeon on a scale of 0 to 10, 3 minutes and 10 minutes after delivery of babyTimepoint: T1-3 min After delivery of baby <br/ ><br>T2-10 min After delivery of baby;To compare the adverse effects of Carbetocin and Oxytocin on the parturientTimepoint: T1